|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Less: Cost of revenues | |||||
| Less: Operating expenses: | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Allowance for expected credit losses | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other (expense)/income: | |||||
| Interest expense | |||||
| Foreign exchange gains/(losses), net | |||||
| Gain from investment | |||||
| Other income, net | |||||
| Total other (expense)/income, net | |||||
| Loss before income taxes | |||||
| Income tax (expense)/benefit | |||||
| Net loss | |||||
| Other comprehensive income/(loss): | |||||
| Foreign currency translation adjustment | |||||
| Comprehensive loss | |||||
| Less: Comprehensive (loss) income attributable to the non-controlling interest | |||||
| Comprehensive loss | |||||
| Less: Comprehensive (loss)/income attributable to the non-controlling interest | |||||
| Comprehensive loss attributable to owners of the Company | |||||
| Net loss per ordinary share: | |||||
| Basic (in Dollars per share) | |||||
| Diluted (in Dollars per share) | |||||
| Weighted average number of ordinary shares outstanding: Basic (in Shares) | |||||
| Weighted average number of ordinary shares outstanding: Diluted (in Shares) | |||||
| Less: Net loss/(income) attributable to non-controlling interest | |||||
| Net loss attributable to owners of the Company | |||||
Loading...